Cellectis (CLLS) Misses Q4 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.22 million versus the consensus estimate of $21.71 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Green Plains Renewable Energy (GPRE) PT Raised to $20 at UBS Ahead of Q2 Results
• CAE and Saab sign MoU for Gripen training support in Canada